Ceapro using patented technology to disrupt the natural health care products - Gilles Gagnon, President and Chief Executive Officer, Ceapro 00:00:00
Mr. Gagnon has participated in several international committees and strategic advisory boards. He completed three mandates on the board of directors of Canada's Research-Based Pharmaceutical Companies (Rx&D, now Innovative Medicine Canada) where he represented for nine years members from the biopharmaceutical sector and pioneered the Rx&D's Canadian bio partnering initiative.